COHERUS

pharmaceuticals for human immune diseases and conditions; pharmaceuticals for use in stimulating white blood cell production; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of inflammation; Pharmaceuticals for the treatment of cancer, autoimmune diseases, metabolic diseases, or ophthalmic diseases and conditions; Pharmaceutical preparations for the prevention and treatment of auto-immune, inflammatory, hematological, hepatological, cardiovascular, pulmonary, central nervous system, neurological system, pain, inflammation, dermatologic, gastro-intestinal, hormonal, psychiatric, infectious-related, viral, metabolic, oncologic, ophthalmic, respiratory, digital ulcers, musculo-skeletal, genitourinary, sexual dysfunction, and cerebrovascular diseases and disorders; vaccines; anxiolytics; anti-allergics; anti-infectives; pharmaceutical preparations for treatment of ocular diseases and disorders; pharmaceuticals for the treatment of oncology, immunology, ophthalmology diseases and disorders